Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells

Blood
Emmanuelle MenoretCatherine Pellat-Deceunynck

Abstract

We evaluated the ability of 2 human mAbs directed against TRAILR1 (HGS-ETR1) and TRAILR2 (HGS-ETR2) to kill human myeloma cells. HGS-ETR1 and HGS-ETR2 mAbs killed 15 and 9 human myeloma cell lines (HMCLs; n = 22), respectively. IL-6, the major survival and growth factor for these HMCLs, did not prevent their killing. Killing induced by either HGS-ETR1 or HGS-ETR2 was correlated with the cleavage of Mcl-1L, a major molecule for myeloma survival. Mcl-1L cleavage and anti-TRAILR HMCL killing were dependent on caspase activation. Kinetic studies showed that Mcl-1L cleavage occurred very early (less than 1 hour) and became drastic once caspase 3 was activated. Our data showed that both the extrinsic (caspase 8, Bid) and the intrinsic (caspase 9) pathways are activated by anti-TRAIL mAb. Finally, we showed that the HGS-ETR1 and, to a lesser extent, the HGS-ETR2 mAbs were able to induce the killing of primary myeloma cells. Of note, HGS-ETR1 mAb was able to induce the death of medullary and extramedullary myeloma cells collected from patients at relapse. Taken together, our data clearly encourage clinical trials of anti-TRAILR1 mAb in multiple myeloma, especially for patients whose disease is in relapse, at the time of drug resistance.

References

Jun 5, 1997·The New England Journal of Medicine·R Bataille, J L Harousseau
Dec 3, 1999·British Journal of Haematology·D PuthierM Amiot
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Josie Ursini-SiegelSelina Chen-Kiang
Mar 3, 2004·Cancer Research·Rafael FonsecaHerve Avet-Loiseau
Apr 20, 2004·Blood·Teru HideshimaKenneth C Anderson
Sep 10, 2004·Leukemia·O Micheau, D Mérino
Oct 2, 2004·European Journal of Immunology·Patricia Gomez-BougieMartine Amiot
Oct 7, 2004·Cell Cycle·Steven Le GouillKenneth C Anderson
Oct 12, 2004·The International Journal of Biochemistry & Cell Biology·Jorg MichelsGraham Packham
Nov 13, 2004·Cell Research·Fiona C Kimberley, Gavin R Screaton
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·S BouralexisA Evdokiou
Feb 19, 2005·Science·Joseph T OpfermanStanley J Korsmeyer
Mar 26, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Caroline M M Van GeelenSteven de Jong
Mar 31, 2005·Blood·John C Reed, Maurizio Pellecchia
May 27, 2005·British Journal of Haematology·Stéphane DepilThierry Facon
Feb 16, 2006·The Journal of Biological Chemistry·Jie HanHannah Rabinowich

❮ Previous
Next ❯

Citations

Aug 20, 2011·Leukemia·N W C J van de DonkH M Lokhorst
Nov 13, 2008·Haematologica·Grégoire DesplanquesSophie Barillé-Nion
Jul 4, 2012·International Journal of Molecular Sciences·Carmela Dantas-BarbosaAndrea Queiroz Maranhao
Sep 13, 2014·Hematology/oncology Clinics of North America·Jooeun BaeKenneth C Anderson
Nov 3, 2011·Bone Marrow Research·Yu-Tzu Tai, Kenneth C Anderson
Dec 9, 2009·FEBS Letters·Emmanuelle MénoretMartine Amiot
Oct 28, 2009·Expert Opinion on Biological Therapy·Norma Lynn FoxGilles Gallant
Jul 20, 2011·Cancer Letters·Nathalie DroinEric Solary
Jul 9, 2008·Current Opinion in Immunology·Nils Lonberg
Feb 3, 2009·British Journal of Haematology·Michel JourdanBernard Klein
Mar 20, 2013·European Journal of Haematology·Alessandro AllegraCaterina Musolino
Jan 30, 2014·International Journal of Cancer. Journal International Du Cancer·Mingjun ZhangQing Yi
Mar 26, 2010·Journal of Cellular Biochemistry·Ugo Testa
Aug 26, 2014·Biochemical Pharmacology·Ingrid A M van RoosmalenFrank A E Kruyt
Jul 10, 2014·Blood·Benoît TessoulinCatherine Pellat-Deceunynck
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Avi AshkenaziS Gail Eckhardt
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen LeongS Gail Eckhardt
Feb 2, 2018·Frontiers in Immunology·Carlos Cuesta-MateosCecilia Muñoz-Calleja
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·David ChironGaëtan Jego
Sep 8, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·David ChironGaëtan Jego
Oct 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mathilde RomagnoliSophie Barillé-Nion
Jun 29, 2012·Cancer Research·Sylvanie SurgetCatherine Pellat-Deceunynck
Jul 9, 2021·Apoptosis : an International Journal on Programmed Cell Death·Xiaofeng DaiJianying Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis